Connor, Clark & Lunn Investment Management (CC&L)’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-58,500
| Closed | -$2.49M | – | 864 |
|
|
2017
Q3 | $2.49M | Hold |
58,500
| – | – | 0.01% | 384 |
|
|
2017
Q2 | $2.52M | Buy |
58,500
+37,800
| +183% | +$1.63M | 0.02% | 352 |
|
|
2017
Q1 | $866K | Sell |
20,700
-300
| -1% | -$12.6K | 0.01% | 513 |
|
|
2016
Q4 | $821K | Sell |
21,000
-19,900
| -49% | -$778K | 0.01% | 519 |
|
|
2016
Q3 | $1.81M | Buy |
+40,900
| New | +$1.81M | 0.01% | 378 |
|